⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

July 21, 2021British Journal of DermatologyOpen Access

Difamilast, a selective phosphodiesterase 4 inhibitor, ointment in paediatric patients with atopic dermatitis: a phase III randomized double-blind, vehicle-controlled trial

View Full Paper

Ask AI

Bookmark

Share

Abstract

Difamilast 0·3% and 1% ointments are superior to vehicle and well tolerated in Japanese paediatric patients with AD.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Saeki et al. (2021) studied this question.

synapsesocial.com/papers/69d8ce83f39dfae3cad17e6c https://doi.org/10.1111/bjd.20655

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Phenotypes of Atopic Dermatitis Depending on the Timing of Onset and Progression in ChildhoodOriginal Research · 2017 · 302 citations
2Japanese guidelines for atopic dermatitis 2017Original Research · 2017 · 151 citations
3OPA-15406, a novel, topical, nonsteroidal, selective phosphodiesterase-4 (PDE4) inhibitor, in the treatment of adult and adolescent patients with mild to moderate atopic dermatitis (AD): A phase-II randomized, double-blind, placebo-controlled studyRCT · 2016 · 107 citations
4Assessment of Pruritus Intensity: Prospective Study on Validity and Reliability of the Visual Analogue Scale, Numerical Rating Scale and Verbal Rating Scale in 471 Patients with Chronic PruritusCohort Study · 2012 · 583 citations
5Addressing treatment challenges in atopic dermatitis with novel topical therapiesReview · 2016 · 67 citations